http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
정우철(Woo Chul Chung),김영옥(Young Ok Kim),나종순(Jong Soon Na),오수혁(Soo Huuk Oh),정인식(In Sik Jung),김정수(Jung Soo Kim),김재성(Jae Sung Kim),김성훈(Sung Hoon Kim) 대한내과학회 1996 대한내과학회지 Vol.50 No.4
The mediastinum is a very uncommon site for a pancreatic pseudocyst. The pancreatic mediastinal pseudocyst is clinically characterized by thecombination of thoracic symptoms with upper abdominal symptoms. The diagnosis is usually made by chest and upper abdominal CT scan, and ERCP. Cystogastrostomy is a treatment of choice. We report a case of mediastinal pancreatic pseudocyst in which a fistulous tract could be confirmed by the injection of radionuclide into the pleural cavity.
3차 의료기관에서 Helicobacter pylori 제균의 성적 질환과 투여된 약제, 투여 기간에 따른 제균의 성적과 제균 후 재감염에 대한 조사
정우철 ( Woo Chul Chung ),조영석 ( Young Seok Cho ),정정조 ( Joeng Jo Jeong ),이인석 ( In Seok Lee ),김상우 ( Sang Woo Kim ),양진모 ( Jin Mo Yang ),최명규 ( Myung Gyu Choi ),정인식 ( In Sik Chung ),박두호 ( Doo Ho Park ) 대한소화기학회 2003 대한소화기학회지 Vol.41 No.1
Background/Aims: Controversies regarding the indications and regimens for the eradication of Helicobacter pylori (H. pylori) still exist. Failure rates have been reported to range from 5% to 10%. This study aimed to evaluate the efforts for the eradication of H. pylori of a tertiary clinic. We assessed the eradication rates according to the diseases, therapeutic regimens, and duration of therapy. In addition, we examined the effectiveness of secondary regimens in patients who failed to respond to primary regimens and the reinfection rate after a successful eradication. Methods: We investigated 389 patients with documented H. pylori infection between January 1996 and December 2001. Results: The overall eradication rate was 79.2%. There were no significant differences in the eradication rates according to the diseases and therapeutic regimens. However, there was a significant difference according to the duration of therapy. Proton pump inhibitor-based 10-day and 14-day regimens were superior to 7-day regimens. The eradication rate of secondary regimens in patients who failed to respond to primary regimens was 76.9%. The reinfection rate after a successful eradication was 4.4%. Conclusions: These results suggest that proton pump inhibitor-based triple regimens with 10 or 14 days of duration should be considered as primary H. pylori eradication therapy. (Korean J Gastroenterol 2003;41:1-8)
Helicobacter pylori 제균요법 적용의 실태 분석: 단일 기관 연구
정우철 ( Woo Chul Chung ),이강문 ( Kang Moon Lee ),백창렬 ( Chang Nyol Paik ),이정록 ( Jeong Rok Lee ),정성훈 ( Sung Hoon Jung ),김진동 ( Jin Dong Kim ),한석원 ( Sok Won Han ),정인식 ( In Sik Chung ) 대한소화기학회 2009 대한소화기학회지 Vol.53 No.4
목적: 현재 H. pylori 제균치료는 소화성 궤양 환자에서만 인정을 받고, 위암이나 위염 환자를 대상으로 적용 범위를 확대 적용하는 것에는 아직 논란의 여지가 있다. 최근 들어 표준 삼제요법의 제균율이 점차 감소하는 경향을 보이며, 이는 항생제 내성의 증가 및 환자의 순응도 감소와 가장 큰 연관이 있으나, 다른 여러 요인들도 제균율에 영향을 미치는 것으로 알려져 있다. 저자들은 진료과에 따른 제균율의 차이가 있는지 알아보기 위해 진료과별 제균치료 현황과 제균율, 그리고 내시경적인 궤양에 대한 적용 빈도를 조사하였다. 대상 및 방법: 2003년 1월부터 2007년 6월까지 가톨릭대학교 성빈센트병원에서 H. pylori 제균요법을 시행했던 환자를 대상으로 소화기내과, 일반내과, 가정의학과별로 제균율의 차이를 후향 조사하였다. 대상 환자는 2,050명으로 의료영상 저장 전송 체계(PACS)를 이용하여 3명의 내시경전문의가 각각의 내시경 소견을 다시 판독하여 내시경적인 미란과 궤양을 구분하였다. 결과: 일차 삼제요법에 대한 제균율은 82.5%였고, 이차 사제요법에 대한 제균율은 71.2%였다. 일차 진료를 담당하는 가정의학과와 내과 일반에서 소화기내과에 비해 내시경적인 미란에 대해 제균요법을 시행하는 빈도가 의미 있게 높았고, 전체 제균율과 내시경적인 궤양에 대한 제균율은 유의하게 낮았다. 결론: 일차 진료과에서 적용한 H. pylori 제균요법은 미란 등 부적절한 제균대상이 많았다. 전체적인 제균율이나 내시경적인 궤양에 대한 제균율은 소화기내과가 일차 진료과에 비해 의미 있게 높았고, 이것은 여러 가지 복합적인 요인이 작용하고 있을 것이며, 그 중에서도 복약에 대한 환자의 순응도가 중요한 역할을 할 것으로 본다. Background/Aims: Eradication rates of Helicobacter pylori (H. pylori) tend to decrease over the last few years. Apart from the antibiotic resistance and patient`s compliance, various factors have an influence on the efficacy of eradication therapy. We analyzed the inter-departmental differences in the eradication therapy for H. pylori infection. Methods: Between January 2003 and June 2007, total 3,072 eradication regimens were prescribed to patients. Eradication rates according to departments-gastroenterology (GE), general internal medicine (IM) and family medicine (FM)-were analyzed retrospectively. Results: The overall eradication rate of first-line triple therapy was 82.5% and second-line quadruple therapy was 71.2%. In the department of IM and FM, the eradication therapy was applied more frequently to the patients with erosion only, not ulcer. Overall eradication rates according to the departments were 87.0% in GE, 81.1% in IM and 77.2% in FM (p=0.02 GE vs. IM and p<0.01 GE vs. FM, respectively). Eradication rate in patients with peptic ulcer was also significantly higher in GE compared with IM or FM. Conclusions: In primary clinic (IM and FM), the eradication therapy was frequently applied to erosion. The eradication rates of H. pylori in GE department were significantly higher than those of IM or FM. Inter-departmental differences of the eradication rate might be caused by patients` compliance to prescribed medication. (Korean J Gastroenterol 2009;53:221-227)
민준기(Jun Ki Min),정우철(Woo Chul Jung),백기현(Gi Hyun Baek),김양리(Yang Ree Kim),오수혁(Soo Hyuk Oh),강문원(Moon Won kang),정인식(In Sik Chung),양우진(Woo Jin Yang),김성훈(Sung Hun Kim) 대한내과학회 1996 대한내과학회지 Vol.51 No.4
Objectives: Tsutsugamushi disease is an acute, febrile illness of humans that is caused by Rickettsia tsutsugamushi. Hypoalbuminemia was reported in some cases of tsutsugamushi disease, but its frequcncy and etiology were not clarified. Therefore we prospectively evaluated fourteen cases of Tsutsugamushi disease patients to idendify intestinal protein loss as a cause of hypoalbuminemia and to assess the value of 99mTc-HSA abdominal scintigraphy for detecting intestinal protein loss. Methods: From November 1994 to December 1994, in fourteen patients with tsutsugamushi disease, serum albumin level and fecal a-1-antitrysin excretion were measured at admission. Anterior abdominal images were obtained at 2, 4, and 24hours after intravenous injection of 30 mCi of Tc-Human serum albumin. Results: 1) The age distribution was mainly in the forties, and fifties. Geographically, 10 cases in the northern part of Kyung-Ki Do and 4 cases in Seoul were occurred. 2) Laboratory findings showed hypoalbuminemia in 5 cases(35.7%), elevated AST and ALT in 11 cases (78.6%), prolonged prothrombin time in 1 cases (7.1%), and proteinuria(30mg/dl) in 9 cases(64.3%). 3) Fecal a-1-antitrypsin concentration was measured in 10 cases of 14 patients with tsutsugamushi disease, of which 8 cases revealed abnormally elevated concentration of fecal a-l-antitrypsin(2.6mg/g dry weight). 4) 99mTc-HSA scintigraphy was positive in 11 of 1478.696) patients with tsutsugamushi disease. 5) In patients with positive 99mTc-HSA scintigraphy, protein loss sites were small bowel(6/11, 54.5%), descending colon(3/14, 27.3%), ascending colon(2/11, 18.1%). Conclusion: Intestinal protein loss was idendified in some patients with tsutsugamushi disease by the measurement of fecal a-1-antitrpysin concentration. 99mTc-HSA scintigraphy is easy and readily available study for detecting intestinal protein loss sites. The comparison of the severity of intestinal protein loss before and after treatment is recommended in patients with tsutsugarnushi disease who have abnormal intestinal protein loss.
궤양성 대장염 질병 활동성 평가에서 도플러 초음파의 유용성
오유석 ( You Suk Oh ),정우철 ( Woo Chul Chung ),황성수 ( Sung Su Hwang ),이강문 ( Kang Moon Lee ),백창렬 ( Chang Nyol Paik ),조영석 ( Young Seok Cho ),이보인 ( Bo In Lee ),최규용 ( Gyu Yong Choi ) 대한소화기학회 2010 대한소화기학회지 Vol.56 No.6
Background/Aims: Disease activity in ulcerative colitis (UC) is generally assessed using symptoms, laboratory data, endoscopic findings, and histology of the biopsy specimens. In this study, we compared disease activity of UC as determined by clinical features and endoscopic findings, and aimed to assess the clinical usefulness of Doppler sonography. Methods: The duplex Doppler sonography of superior mesenteric artery (SMA) and inferior mesenteric artery (IMA) of 10 patients with clinically inactive UC and 20 patients with active UC were evaluated by one radiologist who was blinded to clinical information. Peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI), and pulsatility index (PI) of the SMA and IMA were evaluated. All patients underwent biochemical and endoscopic evaluations thereafter. Correlation between disease activity by the Truelove-Witts classification and the Mayo scoring system was measured, and we compared hemodynamic parameters between active and inactive UC. Results: Correlation rate of disease activity between these two scoring systems was 93.3%. Flow velocities (PSV, p<0.001 and EDV, p=0.03) and PI (p=0.03) were significantly higher in patients with active UC than inactive UC. PSVs of the SMA and IMA were also significantly correlated with disease severity. The active UC could be accurately diagnosed using Doppler sonography (AUC=0.83; 95% confidence interval 0.68-0.99). Conclusions: In patients with UC, clinical stage was well matched with endoscopic disease activity. Doppler sonography was a readily available method, and PSV of SMA would be clinically useful in predicting of disease activity and severity. (Korean J Gastroenterol 2010;56:346-352)
헬리코박터 관련 소화성궤양 환자에서 위산펌프길항제 사용이 요소호기검사 결과에 미치는 영향
옥주현 ( Ju Hyun Oak ),정우철 ( Woo Chul Chung ),정성훈 ( Sung Hoon Jung ),최강현 ( Kang Hyun Choi ),김은정 ( Eun Jung Kim ),강봉구 ( Bong Koo Kang ),강보라미 ( Bo Ra Mi Kang ),공시은 ( Si Eun Kong ),백창렬 ( Chang Nyol Paik ),이 대한소화기학회 2011 대한소화기학회지 Vol.57 No.1
Background/Aims: Revaprazan (Revanex(R)) is a novel proton pump inhibitor (PPI) that has a somewhat different effect on proton pump compared with the other PPI`s, also (called as `acid pump antagonist`). We aimed to examine the false negative rate of (13)C-urea breath test (UBT) in the patients with Helicobacter pylori (H. pylori) associated peptic ulcer disease who were treated with revaprazan and evaluate the anti-urease activity of revaprazan. Methods: Total 55 patients were enrolled in this study. They received EGD examination between January 2009 and December 2009 and diagnosed histologically as H. pylori associated peptic ulcer disease. All patients took revaprazan only. Three patients were excluded because of underlying chronic disease and inappropriate breath sampling. The remaining 52 patients had UBT at 0, 2 and 4 weeks of revaprazan use. After 2 weeks of the cessation of revaprazan, they had the fourth UBT. Results: At 2 and 4 weeks, the false negative rates of UBT were 5.8% and 23.1%, respectively (p=0.05). After 2 weeks of the cessation, the cases of the false negative result were five. Four out of five patients had prolonged negative results on two or three successive tests, and baseline (13)C difference value did not predict the false negative results. Conclusions: False negative results of UBT were common and increased with prolonged use of acid pump antagonist. As PPI, it had also anti-urease activity and most patients (47/52, 90.4%) reverted to positive results by 2 weeks after the cessation of taking the medication. (Korean J Gastroenterol 2011;57:8-13)
이혜원 ( Hye Won Lee ),정우철 ( Woo Chul Chung ),이강문 ( Kang Moon Lee ),백창렬 ( Chang Nyol Paik ),김지희 ( Ji Hee Kim ),전효신 ( Hyo Sin Jeon ),전경화 ( Kyong Hwa Jun ),진형민 ( Hyung Min Chin ) 대한소화기학회 2012 대한소화기학회지 Vol.60 No.1
Portal vein thrombus has been detected in patients with liver cirrhosis, pancreatitis, ulcerative colitis, septicemia, myeloproliferative disorder, and neoplasm. The formation of portal tumor thrombus by hepatocellular carcinoma is well recognized, because of its high incidence, and subsequent development of portal hypertension such as rupture of varices, ascites and liver failure indicates the poor prognosis. In gastric cancer, portal hypertension as an initial presentation is extremely rare. Herein we report a case presenting as portal hypertension caused by tumor thrombus without invasion of liver parenchyma. It is presumed to be intraluminal tumor thrombus originating from primary foci of gastric adenocarcinoma. Tumor thrombus in the portal vein is demonstrated on the PET-CT. (Korean J Gastroenterol 2012;60:42-46)
박성민 ( Sung Min Park ),정우철 ( Woo Chul Chung ),이강문 ( Kang Moon Lee ),백창렬 ( Chang Nyol Paik ),정성훈 ( Sung Hoon Jung ),이정록 ( Jeong Rok Lee ),최명규 ( Myung Gyu Choi ),강유진 ( Yoo Jin Kang ) 대한소화기기능성질환·운동학회 2008 Journal of Neurogastroenterology and Motility (JNM Vol.14 No.2
Stellate ganglion block therapy is widely practiced in pain control and a wide variety of disease, though the precise mechanisms are indistinct. Stellate ganglion block may be indicated for the treatment of sympathetically mediated pain, idiopathic hypertension, hot flush, allergic rhinitis, insomnia, chronic constipation and irritable bowel syndrome. The therapeutic efficacy may improve the autonomic nervous, endocrine and immune system and thus restore the homeostasis of the body. We experienced a 40-year-old patient with chronic constipation and slow transit who did not respond to medical therapy. His clinical symptoms improved by stellate ganglion block and there was no recurrence. (Kor J Neurogastroenterol Motil 2008;14:129-132)